>_ QFI Terminal
Terminal › Stocks › DMIIR

Drugs Made In America Acquisition II Corp. Right (DMIIR) Stock

Financial Services · Asset Management · US
$0.07 +32.08%
Last updated Nov 12, 2026 10:46 UTC

DMIIR Key Statistics

Market Cap$4.46M
P/E (TTM)-24.14
P/S (TTM)—
P/B (TTM)0.01
Revenue (TTM)$0.00
EPS (TTM)$0.00
Dividend Yield—
ROE (TTM)-0.09%
Net Margin0.00%
Gross Margin0.00%
52W High$0.13
52W Low$0.05
Analyst View—
Price Target—
Employees—
Volume10,519

About Drugs Made In America Acquisition II Corp. Right

Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.

CEO: Roger Bendelac. Company website

DMIIR — Frequently Asked Questions

What is the DMIIR stock price today?

Drugs Made In America Acquisition II Corp. Right (DMIIR) trades at $0.07, up 32.08% on the day, as of Nov 12, 2026 10:46 UTC.

What is Drugs Made In America Acquisition II Corp. Right's market cap?

Drugs Made In America Acquisition II Corp. Right has a market capitalisation of $4.46M, calculated from the live DMIIR share price and shares outstanding.

What is the P/E ratio of DMIIR?

DMIIR has no meaningful price-to-earnings ratio: Drugs Made In America Acquisition II Corp. Right lost $0.00 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does Drugs Made In America Acquisition II Corp. Right make?

Drugs Made In America Acquisition II Corp. Right generated revenue of $0.00 over the trailing twelve months.

What is the 52-week range for DMIIR?

DMIIR has traded between $0.05 and $0.13 over the past 52 weeks, and the last price is 46.2% below that high.

Is Drugs Made In America Acquisition II Corp. Right profitable?

Yes. Drugs Made In America Acquisition II Corp. Right keeps 0.00% of revenue as net income over the trailing twelve months.

What sector is Drugs Made In America Acquisition II Corp. Right in?

Drugs Made In America Acquisition II Corp. Right is classified under the Financial Services sector and the Asset Management industry, and is domiciled in US .

Who is the CEO of Drugs Made In America Acquisition II Corp. Right?

Roger Bendelac is the chief executive of Drugs Made In America Acquisition II Corp. Right.

Where can I track DMIIR in real time?

QFI Terminal shows DMIIR with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See DMIIR live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open DMIIR in Terminal See plans

Asset Management stocks

BN Brookfield Corporation APO Apollo Global Management, Inc. BLK BlackRock, Inc. CRBG Corebridge Financial, Inc. KKR KKR & Co. Inc. AMP Ameriprise Financial, Inc. RJF Raymond James Financial, Inc. PFG Principal Financial Group, Inc. BX Blackstone Inc. STT State Street Corporation EQH Equitable Holdings, Inc. BEN Franklin Resources, Inc. PX P10, Inc. TROW T. Rowe Price Group, Inc. IVZ Invesco Ltd. BAM Brookfield Asset Management Ltd. ARES Ares Management Corporation NTRS Northern Trust Corporation TPG TPG Inc. CG The Carlyle Group Inc. SEIC SEI Investments Company AMG Affiliated Managers Group, Inc. OWL Blue Owl Capital Inc. HLNE Hamilton Lane Incorporated

More Financial Services stocks

KB KB Financial Group Inc. MUFG Mitsubishi UFJ Financial Group, Inc. HDB HDFC Bank Limited IBN ICICI Bank Limited CNCK Coincheck Group N.V. ITUB Itaú Unibanco Holding S.A. BRK-B Berkshire Hathaway Inc. JPM JPMorgan Chase & Co. C Citigroup Inc. RY Royal Bank of Canada HSBC HSBC Holdings plc WFC Wells Fargo & Company MS Morgan Stanley GS The Goldman Sachs Group, Inc. BAC Bank of America Corporation TD The Toronto-Dominion Bank